Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Multicenter Trial For Patients With Acute Crohn's Disease

ClinicalTrials.gov ID: NCT00035503

Public ClinicalTrials.gov record NCT00035503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 8:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00035503
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • etiprednol dicloacetate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 30, 2002
Primary completion
Jan 30, 2004
Completion
Jan 30, 2004
Last update posted
Dec 7, 2021

2002 – 2004

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Stuart Weisman Palo Alto California 94304
University of Colorado Medical Center Denver Colorado 80262
Washington Hospital Center Washington D.C. District of Columbia 20010
Mark Lamet Hollywood Florida 33021
Wayne Schonfeld Hollywood Florida 33021
Mount Sinai Medical Center Miami Beach Florida 33140
University of Chicago Hospital Medical Center Chicago Illinois 60637
Gerald Dryden Louisville Kentucky 40202
Richard MacDermott Albany New York 12208

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00035503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 7, 2021 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00035503 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →